| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 62.82 mm | 62.82 mm | 62.82 mm | 62.82 mm | 62.82 mm | 62.82 mm |
| Cash burn (monthly) | (no burn) | 2.38 mm | 5.95 mm | 5.19 mm | (no burn) | 2.97 mm |
| Cash used (since last report) | n/a | 6.71 mm | 16.76 mm | 14.63 mm | n/a | 8.37 mm |
| Cash remaining | n/a | 56.11 mm | 46.06 mm | 48.20 mm | n/a | 54.45 mm |
| Runway (months of cash) | n/a | 23.6 | 7.7 | 9.3 | n/a | 18.3 |
| 13F holders | Current |
|---|---|
| Total holders | 52 |
| Opened positions | 29 |
| Closed positions | 6 |
| Increased positions | 4 |
| Reduced positions | 5 |
| 13F shares | Current |
|---|---|
| Total value | 37.06 bn |
| Total shares | 41.70 mm |
| Total puts | 4.00 k |
| Total calls | 8.50 k |
| Total put/call ratio | 0.5 |
| Largest owners | Shares | Value |
|---|---|---|
| BGNE BeiGene | 12.15 mm | $43.39 mm |
| GILD Gilead Sciences | 5.32 mm | $16.17 mm |
| Artal International S.C.A. | 4.00 mm | $12.96 mm |
| LLY Eli Lilly and | 3.15 mm | $10.21 mm |
| Balyasny Asset Management | 3.09 mm | $7.93 bn |
| Samsara BioCapital | 2.44 mm | $7.33 mm |
| Samsara BioCapital | 2.44 mm | $6.28 bn |
| 683 Capital Management | 1.38 mm | $3.55 bn |
| Rock Springs Capital Management | 1.27 mm | $3.26 bn |
| Baker Bros. Advisors | 1.17 mm | $3.01 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 Nov 24 | Lawlor Augustine | Common Stock | Acquire X | Yes | No | 2.82 | 2,136 | 6.02 k | 678,456 | |
| 13 Nov 24 | Lawlor Augustine | Warrant Common Stock, $0.001 par value per share | Dispose X | Yes | No | 2.82 | 2,136 | 6.02 k | 0 | |
| 13 Nov 24 | Mirabelli Christopher | Common Stock | Acquire X | Yes | No | 2.82 | 2,136 | 6.02 k | 678,456 | |
| 13 Nov 24 | Mirabelli Christopher | Warrant Common Stock, $0.001 par value per share | Dispose X | Yes | No | 2.82 | 2,136 | 6.02 k | 0 | |
| 13 Nov 24 | Onsi Douglas E | Common Stock | Acquire X | Yes | No | 2.82 | 2,136 | 6.02 k | 678,456 | |
| 13 Nov 24 | Onsi Douglas E | Warrant Common Stock, $0.001 par value per share | Dispose X | Yes | No | 2.82 | 2,136 | 6.02 k | 0 | |
| 13 Nov 24 | James H Cavanaugh | Common Stock | Acquire X | No | No | 2.82 | 213 | 600.66 | 213 | |
| 13 Nov 24 | James H Cavanaugh | Warrant Common Stock, $0.001 par value per share | Dispose X | No | No | 2.82 | 213 | 600.66 | 0 | |
| 2 Oct 24 | Lawlor Augustine | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.45 | 85,000 | 208.25 k | 85,000 |
